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The aqueous leaf extract of Vernonia amygdalina was evaluated for its prebiotic effects on seven human 
volunteers, made up of five men and two women. The evaluation was conducted by monitoring the 
effects of oral administration of the extract on total and differential counts of aerobic faecal  bacteria, 
bowel changes and other physiological parameters. Three main bacterial types (Enterococcus sp. 
Lactobacillus sp. and Corynebacterium sp.) were isolated from the stool samples of the subjects. 
Enterococcus sp. was selectively stimulated over the other species by the extract and increase in 
numbers of Lactobacillus appeared to be dependent on the metabolic activities of Enterococcus. The 
subjects reported changes in bowel function including increased faecal volume, softening of stool and 
flatulence; effects which have been associated with known prebiotics. Evaluation of possible antagonism 
between the intestinal bacteria and other bacteria showed that while there was no antagonism between 
the three faecal isolates, Lactobacillus exhibited antagonism against intestinal pathogens such as 
Escherichia coli, Salmonella, Staphylococcus, Shigella and Klebsiella. The results from this study show 
convincingly that aqueous leaf extracts of V. amygdalina contains prebiotics. Furthermore there is a 
strong suggestion that oral administration of this extract may enhance the production of vitamins, 
particularly folate, in the intestinal environment by intestinal bacteria. 
 




Prebiotics are non-digestable food ingredients that 
selectively stimulate the growth of a limited number 
of beneficial microorganisms in the intestinal tract to 
improve host health (Gibson and Roberfroid, 1995; 
Cummings et al., 2001; De Vuyst et al., 2005; 
Rastall et al., 2005). 
For decades, the roles of the intestinal 
microflora in maintaining the structure and function 
of the intestine have been documented. These roles 
include those of digestion, fermentation, inhibition of 
pathogenic organisms, provision of enzymes and 
amino acids, and development of immunity 
(Macfarlane and Cummings, 1999; Matsuki et al., 
1999; Cummings et al., 2001; Morelli et al., 2003; 
Tannock et al., 2004; Rastall et al., 2005). Interest 
in these beneficial roles of the intestinal microflora 
has led to the development of various types of 
probiotic foods, that is, foods containing live 
microorganisms; for example, yoghurt (Macfarlane 
and Cummings, 1999). The use of probiotics has, 
however, been faced with a serious problem of 
consumer confidence because many individuals are 
skeptical about consuming live microorganisms, 
regardless of the propounded benefits. Also, some 
such organisms have been known to cause disease 
in immunocompromised individuals (Macfarlane and 
Cummings, 1999). Consequently, attention has 
recently shifted from probiotic to prebiotic studies. 
The most commonly studied and available 
prebiotics are the oligosaccharides, 
galactooligosaccharides and pectic oligo-
saccharides (Menne et al., 2000; Cummings et al., 
2001; Morelli et al., 2003;  Rastall et al., 2005; De 
Vuyst et al., 2005; Saulnier et al., 2007). These 
complex carbohydrates are non-digestable by the 
gastric juice, pancreatic and brush border enzymes 
and selectively stimulate the growth of intestinal 
microflora. These carbohydrates are commonly 
found in fruits, vegetables and plant products 
(Menne et al.,2000; Rastall et al., 2005). 
This study aimed at evaluating the 
prebiotic effects of Vernonia amygdalina leaf 
extracts. The leaves are commonly used in Nigeria 
especially in Igbo traditional medicne for treating 
various illnesses including gastrointestinal 
disturbances. Vernonia amygdalina, commonly 
called “bitterleaf” in English and “Olubu or Onugbo” 
in Ibo is a small shrub that grows predominantly in 
tropical Africa. There have been several reports on 
its antimicrobial, antiplasmodial, antitumor, 
antioxidant and antihelminthic properties (Jisaka et 
al., 1993; Izevbigie, 2003; Farombi, 2003; 
Ehiagbonare, 2007), but no reports yet on the 
prebiotic effects, which was investigated in this 
study. 
The specific objectives of the study were: 
to evaluate the effects of the V. amygdalina 
aqueous extract on total and differential counts of 
the intestinal microflora; to isolate and characterize 
the organism (s) that is (are) stimulated by the 
extract; and to study, in vitro, possible antagonistic 
interactions between the organisms of the 
microflora and between the microflora and some 
other organisms including intestinal pathogens. 
  
Materials and Methods 
 
Test plant: The leaves of the plant, Vernonia 
amygdalina, used for this study were obtained from 
a private farm in Nsukka and authenticated by a 
botanist from the Department of Botany, University 
of Nigeria, Nsukka. 
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Human volunteers: Twelve volunteers, made up of 
seven males and five females were randomly 
recruited from the student population of University 
of Nigeria, Nsukka. Subjects were asked to provide 
information on their general health. Only individuals 
having no history of gastrointestinal disease and 
who were not using any antibiotics for at least three 
months prior to the commencement of the study, 
were selected. Informed consent was obtained from 
the volunteers according to the ethical guidelines of 
the University of Nigeria, Nsukka. 
 
Extraction procedure: The leaves were washed in 
clean water and dried. The dried leaves were 
crushed into a homogenous powder using mortar 
and pestle. One hundred grams (100 g) of the 
powder was soaked in 1 L of water for 24 h with 
intermittent stirring. The aqueous extract was then 
filtered through a 2 mm mesh filter and the filtrate 
stored at 4oC in clean sterile bottles. 
 
Effect of the extract on human intestinal flora: 
This phase of the study was carried out over a six-
week period. In the first stage, lasting two weeks, 
no extract was administered, while the faecal flora 
of the subjects was monitored. This period was 
called the pretreatment period. In the second stage 
of another two weeks, 150 ml of the extract, given in 
form of a drink, was administered once daily, 
usually with or immediately after supper. The 
changes in type and numbers of the faecal flora 
were monitored. This period was called the 
treatment period. During the last stage, lasting 
another two weeks, the extract was again excluded 
while monitoring of the faecal flora continued. This 
period was called the post-treatment period. The 
subjects were given strict instructions to eliminate 
fruit juices, soft drinks, yoghurt, alcohol and 
antibiotics from their diets for the duration of the 
study, but water and other daily diets were allowed. 
 
Collection and processing of faecal samples: 
Fresh stool samples were obtained every three 
days from the subjects throughout the study period. 
All samples were processed aerobically and 
microaerophilically (in anaerobic jars) within 3 h of 
collection. Each faecal sample was homogenized 
(10%, w/v) in sterile phosphate buffered saline 
comprising (w/v): sodium chloride, 0.8%; potassium 
phosphate, 0.2%; sodium phosphate, 0.115%; at 
pH 7.4. Following homogenization, dilutions of 
faecal suspension were inoculated onto agar media 
including Nutrient, De Man, Rogosa and Sharpe 
(MRS) agars (Oxoid). Cultures were prepared in 
triplicates and incubated both aerobically and 
microaerophilically at 37oC for 48 h. 
 
Enumeration of intestinal organisms: Colonies 
resulting from the 48 h faecal cultures were 
enumerated and characterized based on cultural, 
morphological and biochemical characteristics as 
outlined in District Laboratory Practice in Tropical 
Countries (Cheesbrough, 2004) and Manual of 
Clinical Microbiology (Balows et al., 1991). 
Organisms were identified to at least genus level. 
 
Evaluation of bowel functions: The changes in 
bowel function as well as general health conditions 
of the subjects were monitored throughout the study 
by oral interview of the subjects as well as visual 
examination of the faecal samples. 
 
Antagonistic evaluation of isolates: The faecal 
isolates were evaluated for antagonistic properties 
against each other and against other bacteria, 
including Salmonella sp., Staphylococcus aureus, 
and Escherichia coli. Each isolate was inoculated 
unto Nutrient or MRS agar and incubated for 24 h at 
37oC. Then, a soft agar, at 42 – 45oC, mixed with 
the test organism, was overlaid on the 24 h culture. 
The co-culture was then incubated for another 24 h. 
Thereafter, inhibition zones of the test organisms 
were observed and measured. 
 
Statistical analysis: The counts of faecal 
organisms were analyzed for differences due to the 
consumption of the test extract. Analysis of 
Variance (ANOVA) and Least Significant Difference 
(LSD) determinations were used to test for 
differences between baseline bacterial counts 
during the pretreatment period, increases during the 
treatment period and post-treatment periods. 




Human volunteers: Twelve volunteers, including 
seven males and five females were initially recruited 
for the study. However, five people (two males and 
three females) opted out before the completion of 
the study. Consequently, results were obtained from 
only seven subjects. 
 
Enumeration of intestinal organisms: A total of 
eight organisms were isolated from the stool 
samples of the subjects. These faecal bacteria were 
identified as Staphylococcus aureus, Bacillus 
cereus, Lactobacillus sp., Enterococcus sp., 
Corynebacterium sp., Proteus sp., coagulase 
negative Staphylococcus sp. and Pseudomonas 
aeruginosa. Some of the species occurred in an 
irregular pattern and in low numbers during different 
phases of the study and were regarded as transient 
flora, while others occurred consistently throughout 
all phases of the study. These were regarded as the 
resident intestinal flora. These members of the 
resident flora were Lactobacillus sp., Enterococcus 
sp. and Corynebacterium sp. The relative 
abundance of the different organisms through the 
different phases of the study are shown in Table 1. 
 
Effect of consumption of extract on bacterial 
counts: The numbers of organisms per gram of 
stool of the three members of the intestinal 
microflora were monitored for all seven subjects. 
Similar patterns were observed for all seven 
subjects and the results for four of the subjects are 
shown in Figures 1 to 4. There was a noticeable 
increase in the number of enterococci, beginning 
within 72 h following administration of the extract. 
The numbers rose steadily throughout the treatment 
period, declining with ceasation of treatment 
(Figures 1 – 4).  
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Table 1. Relative abundance of organisms isolated from stool samples during the different periods of the 
study 

























Staphylococcus aureus + + + + - - - - - - - - 
Bacillus cereus + + + + - - + - - - - + 
Lactobacillus sp. + + + + + + ++ ++ +++ +++ +++ + 
Enterococcus sp. + ++ ++ ++ +++ +++ +++ +++ +++ +++ +++ ++ 
Corynebacterium sp. + + ++ ++ +++ +++ ++ ++ + + + + 
Proteus sp. + + + - - - - - - - + + 
Coagulase negative 
Staphylococcus 
- - - - - - - - - - + + 
Pseudomonas 
aeruginosa 
- - - + + + - - - - - - 





































Statistical analysis proved this increase to be 
significant at P < 0.05. The increase in number of 
Corynebacterium was more gradual with noticeable 
increases recorded from about the third day, 
reaching a peak by around the seventh day of 
treatment, before declining and dropping to base 
levels with ceasation of treatment  (Figures 1 – 4). 
These increases were not significant (P > 0.05). 
There was a delay in the increase in numbers of 
lactobacilli, with the rise starting only after the peak 
of enterococci. Thus, the increase in number of 
lactobacilli was recorded immediately following 
ceasation of treatment (Figs. 1 – 4). The increase in 



































Change in bowel and physiological functions: 
Oral interview of the subjects revealed that most 
observed a softening of the stool during a few days 
following treatment. There was increase in faecal 
volume, increase in appetite and some individuals 
reported experiencing a sedative effect during 
treatment. In addition to these, most of the subjects 
reported experiencing a brief period of constipation. 
It was noteworthy that these periods coincided with 
the days following the peak of Lactobacillus in each 
of the subjects (Figs. 1 – 4). Also, some individuals 
experienced mild flatulence during treatment (Figs. 
1, 3 and 4). 
 
 
Pretreatment Treatment Post-treatment 
Fig. 1: Effect of oral administration of  V. 
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Fig. 2. Effect of oral administration of V. 
amygdalina aqueous extract on bacterial 
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Interactions between faecal isolates and test 
organisms: Evaluation of possible antagonistic 
interactions between the intestinal flora and 
selected intestinal pathogens showed that only 
Lactobacillus exhibited antagonism against the 




Three bacterial types were found to be consistently 
present in the stool samples of the human subjects 
during the eleven-day monitoring period (pre-
treatment) and were therefore considered to be 
members of the resident intestinal microflora. The 
morphological and biochemical characteristics of 
these organisms were consistent with those of 
Enterococcus, Corynebacterium and Lactobacillus. 
The three organisms were monitored for changes in 
numbers through the pre-treatment, treatment and 
post-treatment periods. The results showed that 
there were changes in the numbers of cells of the 
organisms per gram of stool through the different 
periods of study. Analysis of the data by one-way 
ANOVA and LSD, showed that the numbers of 








Fig. 3: Effect of oral administration of V. 
amygdalina aqueous extract on bacterial 
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Fig. 4: Effect of oral administration of V. 
amygdalina aqueous extract on











0 3 7 11 14 18 22 26 29 33 37 41
Day
Entero co ccus




































(P < 0.05) higher during the treatment period and a 
few days following ceasation of treatment. The 
numbers of Lactobacillus increased significantly (P 
< 0.05) in the first few days after the ceasation of 
treatment, while there was no significant (P > 0.05) 
difference in the numbers of Corynebacterium in the 
different periods. These results suggest that, of the 
three organisms, only Enterococcus was directly 
stimulated by the treatment. 
Enterococcus has previously been listed 
as one of the probiotic bacteria active in the gut 
(Macfarlane and Cummings, 1999; Crittenden et al., 
2003). It has been established that probiotic 
bacteria active in the intestinal tract may be 
stimulated by consumption of certain foods or food 
ingredients (prebiotics). The stimulation of 
Enterococcus in this study, over other identified 
species, suggests that the aqueous extract of V. 
amygdalina leaves contains prebiotic constituents. 
Also, the pattern of increase in bacterial numbers, 
with Lactobacillus coming consistently last, may 
suggest that prebiotic substances present in the 
extract were metabolized by the other organisms to 
release or produce a compound or compounds, 
which were required for the growth of Lactobacillus.  
Softening of stool  
increase in faecal  
volume flatulence 
Constipation 
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Table 2: Interactions between the faecal isolates and selected test bacteria 















Enterococcus sp. - - - - - NT - 
Corynebacterium 
sp. 
- - - - - - NT 
Lactobacillus sp.  + + + + + - + 
Key: -  = No inhibition, + = Inhibition, NT = Not tested 
 
This is in line with the reports of Crittenden et al. 
(2003), which suggested that probiotic bacteria, 
when stimulated by consumption of certain foods 
may produce vitamins, particularly folate, which is 
utilized by lactobacilli.  
Folate is widely distributed in the biological 
world, intestinal bacteria being one source of the 
vitamin. Faecal bacteria, which have been reported 
to produce folate include Enterococcus faecium, 
Streptococcus thermophilus and various species of 
Bifidobacterium (Crittenden et al., 2003; Holasova 
et al., 2004; Pompei et al., 2007). There have 
previously been questions regarding the extent to 
which these probiotic bacteria can contribute to the 
folate requirement of colonic epithelial cells. 
However, experiments by Pompei et al. (2007) 
demonstrated that addition of Bifidobacterium 
adolescentis to the diets of some human volunteers 
increased the folate concentration in the colonic 
environment.  Although there were no attempts to 
assay for production of vitamins in this study, there 
were complaints of constipation by the volunteers 
for a few days in the post-treatment period, 
coincidental with the period immediately following 
the peak of Lactobacillus. Constipation has been 
associated with shortage or deficiency of folate or 
folic acid (Clark, 2008; Whiting, 2008). It is possible 
that rapid consumption of folate by the increased 
numbers of lactobacilli resulted in the temporary 
occurrence of constipation. Most species of 
Lactobacillus have been shown to deplete folate 
concentrations in growth media (Crittenden et al., 
2003). Lactic acid bacteria such as Lactobacillus 
have a strict growth requirement for folic acid 
(Hugenholtz et al., 2002). 
In the large intestine, prebiotics, in addition 
to their selective stimulation of the intestinal 
microflora, influence many aspects of bowel 
function through fermentation. They affect bowel 
habit, are mildly laxative and have a propensity to 
produce flatulence (Cummings et al., 2001). The 
results of the oral interview of the volunteers in this 
study, showed that the volunteers experienced 
various changes in bowel function during the 
treatment period consistent with effects reported for 
prebiotics. The softening of stool and increase in 
faecal volume reported by the volunteers in this 
study are all part of the laxative effect reported for 
prebiotics. According to Cummings et al. (2001), the 
prebiotics produce their laxative effect via 
stimulation of microbial growth, increase in bacterial 
mass, and thus, stimulation of peristalsis by the 
increased bowel content. The flatulence is due to 
the production of carbon dioxide and hydrogen, 
which are two of the major products of prebiotic  
 
 
metabolism, others being short chain fatty acids 
(SCFAs) and bacterial cell mass (Cummings et al., 
2001). 
Another established role of the human 
microflora in health is that of inhibition of various 
human pathogens. By extension, therefore, 
stimulation of the intestinal microflora by whatever 
mechanism, should provide the human involved 
with some protection against intestinal pathogens. 
To evaluate this potential benefit, the intestinal 
species stimulated by the extract in this study, were 
tested for antagonism against each other and some 
selected intestinal pathogens. The results showed 
that only Lactobacillus exhibited antagonism against 
the pathogens. This is in line with the results from a 
study by Clements et al. (1981) in which different 
organisms including lactobacilli, bifidobacteria, 
enterococci and staphylococci were tested for 
prophylactic effectiveness against traveller’s 
diarrhoea and Lactobacillus but not Enterococcus 
was one of the organisms that reduced diarrhoea. 
The results from this study show that V. 
amygdalina leaf extract contains prebiotics, which 
stimulate selected intestinal bacteria, influencing 
bowel functions. Furthermore, there is a strong 
suggestion that oral administration of this extract 
may enhance the production of vitamins, particularly 
folate, in the intestinal environment by intestinal 
bacteria. This study therefore highlights another 
important use of the Vernonia amygdalina plant for 
human health. The V. amygdalina leaves, which are 
commonly used in many parts of Eastern Nigeria for 
soup (bitterleaf soup) can now be recommended for 
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